Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis

BACKGROUND AND OBJECTIVES: Five-tumour necrosis factor (TNF)-blockers (infliximab, etanercept, adalimumab, certolizumab pegol and golimumab) are available for treatment of rheumatoid arthritis. Only few clinical trials compare one TNF-blocker to another. Hence, a systematic review is required to ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Aaltonen, Kalle J., Virkki, Liisa M., Malmivaara, Antti, Konttinen, Yrjö T., Nordström, Dan C., Blom, Marja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264/
https://www.ncbi.nlm.nih.gov/pubmed/22272322
http://dx.doi.org/10.1371/journal.pone.0030275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260264/
https://www.ncbi.nlm.nih.gov/pubmed/22272322
http://dx.doi.org/10.1371/journal.pone.0030275

Ejemplares similares